Skip to Main Content

INFORMATION FOR

The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

A prospective, non blinded, single arm, multicenter study designed to assess the safety and effectiveness of the bioprosthetic, VenoValve, which is surgically implanted into the deep venous system for treatment of patients with deep venous valvular insufficiency ( C4b-C6 patients).

The purpose of this study is to evaluate the VenoValve System (Hancock Jaffe Laboratories) in human patients. The VenoValve System is designed for treatment of chronic deep venous insufficiency. The VenoValve System enables improvement in chronic lower extremity venous reflux through an open surgical technique. The objective of this study is to assess the safety and effectiveness of the VenoValve System for the treatment of patients with deep venous valvular insufficiency and the associated complications.

Watch this video of Drs. Chaar, Aboian, and Guzman, discuss this cutting edge technology for the treatment of Chronic Venous Insufficiency. Yale is one of the leading sites in the US for this study.

  • Trial with
    Hancock Jaffe Laboratories Inc.
  • Start Date
    10/20/2021
  • End Date
    05/31/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000030794